 | • レポートコード：GIR-105X01214 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アルギニン血症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルギニン血症治療薬の種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルギニン血症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Helsinn Healthcare、Novartis Pharmaceuticals、Horizon Pharma、Medicis Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：病院、ドラッグストア、その他 ・アルギニン血症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルギニン血症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルギニン血症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルギニン血症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルギニン血症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Argininemia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Argininemia Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Argininemia Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Argininemia Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Hospital
Drugs Stores
Other
The key market players for global Argininemia Drugs market are listed below:
Helsinn Healthcare
Novartis Pharmaceuticals
Horizon Pharma
Medicis Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Argininemia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Argininemia Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Argininemia Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Global Argininemia Drugs Market Size & Forecast
1.4.1 Global Argininemia Drugs Sales in Value (2016-2026))
1.4.2 Global Argininemia Drugs Sales in Volume (2016-2026)
1.4.3 Global Argininemia Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Argininemia Drugs Production Capacity Analysis
1.5.1 Global Argininemia Drugs Total Production Capacity (2016-2026)
1.5.2 Global Argininemia Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Argininemia Drugs Market Drivers
1.6.2 Argininemia Drugs Market Restraints
1.6.3 Argininemia Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Helsinn Healthcare
2.1.1 Helsinn Healthcare Details
2.1.2 Helsinn Healthcare Major Business
2.1.3 Helsinn Healthcare Argininemia Drugs Product and Services
2.1.4 Helsinn Healthcare Argininemia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis Pharmaceuticals
2.2.1 Novartis Pharmaceuticals Details
2.2.2 Novartis Pharmaceuticals Major Business
2.2.3 Novartis Pharmaceuticals Argininemia Drugs Product and Services
2.2.4 Novartis Pharmaceuticals Argininemia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Horizon Pharma
2.3.1 Horizon Pharma Details
2.3.2 Horizon Pharma Major Business
2.3.3 Horizon Pharma Argininemia Drugs Product and Services
2.3.4 Horizon Pharma Argininemia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Medicis Pharmaceutical
2.4.1 Medicis Pharmaceutical Details
2.4.2 Medicis Pharmaceutical Major Business
2.4.3 Medicis Pharmaceutical Argininemia Drugs Product and Services
2.4.4 Medicis Pharmaceutical Argininemia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Argininemia Drugs Sales by Manufacturer
3.1 Global Argininemia Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Argininemia Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Argininemia Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Argininemia Drugs Manufacturer Market Share
3.4.2 Top 6 Argininemia Drugs Manufacturer Market Share
3.5 Global Argininemia Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Argininemia Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Argininemia Drugs Market Size by Region
4.1.1 Global Argininemia Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Argininemia Drugs Revenue by Region (2016-2026)
4.2 North America Argininemia Drugs Revenue (2016-2026)
4.3 Europe Argininemia Drugs Revenue (2016-2026)
4.4 Asia-Pacific Argininemia Drugs Revenue (2016-2026)
4.5 South America Argininemia Drugs Revenue (2016-2026)
4.6 Middle East and Africa Argininemia Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Argininemia Drugs Sales in Volume by Type (2016-2026)
5.2 Global Argininemia Drugs Revenue by Type (2016-2026)
5.3 Global Argininemia Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Argininemia Drugs Sales in Volume by Application (2016-2026)
6.2 Global Argininemia Drugs Revenue by Application (2016-2026)
6.3 Global Argininemia Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Argininemia Drugs Sales by Type (2016-2026)
7.2 North America Argininemia Drugs Sales by Application (2016-2026)
7.3 North America Argininemia Drugs Market Size by Country
7.3.1 North America Argininemia Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Argininemia Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Argininemia Drugs Sales by Type (2016-2026)
8.2 Europe Argininemia Drugs Sales by Application (2016-2026)
8.3 Europe Argininemia Drugs Market Size by Country
8.3.1 Europe Argininemia Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Argininemia Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Argininemia Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Argininemia Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Argininemia Drugs Market Size by Region
9.3.1 Asia-Pacific Argininemia Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Argininemia Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Argininemia Drugs Sales by Type (2016-2026)
10.2 South America Argininemia Drugs Sales by Application (2016-2026)
10.3 South America Argininemia Drugs Market Size by Country
10.3.1 South America Argininemia Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Argininemia Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Argininemia Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Argininemia Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Argininemia Drugs Market Size by Country
11.3.1 Middle East & Africa Argininemia Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Argininemia Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Argininemia Drugs Typical Distributors
12.3 Argininemia Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Argininemia Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Argininemia Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Helsinn Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. Helsinn Healthcare Major Business
Table 5. Helsinn Healthcare Argininemia Drugs Product and Services
Table 6. Helsinn Healthcare Argininemia Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Pharmaceuticals Major Business
Table 9. Novartis Pharmaceuticals Argininemia Drugs Product and Services
Table 10. Novartis Pharmaceuticals Argininemia Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Horizon Pharma Major Business
Table 13. Horizon Pharma Argininemia Drugs Product and Services
Table 14. Horizon Pharma Argininemia Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Medicis Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Medicis Pharmaceutical Major Business
Table 17. Medicis Pharmaceutical Argininemia Drugs Product and Services
Table 18. Medicis Pharmaceutical Argininemia Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Argininemia Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 20. Global Argininemia Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Argininemia Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Argininemia Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 23. Head Office and Argininemia Drugs Production Site of Key Manufacturer
Table 24. Global Argininemia Drugs Sales by Region (2016-2021e) & (K MT)
Table 25. Global Argininemia Drugs Sales by Region (2021-2026) & (K MT)
Table 26. Global Argininemia Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Argininemia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Argininemia Drugs Sales by Type (2016-2021e) & (K MT)
Table 29. Global Argininemia Drugs Sales by Type (2021-2026) & (K MT)
Table 30. Global Argininemia Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Argininemia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Argininemia Drugs Price by Type (2016-2021e) & (USD/MT)
Table 33. Global Argininemia Drugs Price by Type (2021-2026) & (USD/MT)
Table 34. Global Argininemia Drugs Sales by Application (2016-2021e) & (K MT)
Table 35. Global Argininemia Drugs Sales by Application (2021-2026) & (K MT)
Table 36. Global Argininemia Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Argininemia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Argininemia Drugs Price by Application (2016-2021e) & (USD/MT)
Table 39. Global Argininemia Drugs Price by Application (2021-2026) & (USD/MT)
Table 40. North America Argininemia Drugs Sales by Country (2016-2021e) & (K MT)
Table 41. North America Argininemia Drugs Sales by Country (2021-2026) & (K MT)
Table 42. North America Argininemia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Argininemia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Argininemia Drugs Sales by Type (2016-2021e) & (K MT)
Table 45. North America Argininemia Drugs Sales by Type (2021-2026) & (K MT)
Table 46. North America Argininemia Drugs Sales by Application (2016-2021e) & (K MT)
Table 47. North America Argininemia Drugs Sales by Application (2021-2026) & (K MT)
Table 48. Europe Argininemia Drugs Sales by Country (2016-2021e) & (K MT)
Table 49. Europe Argininemia Drugs Sales by Country (2021-2026) & (K MT)
Table 50. Europe Argininemia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Argininemia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Argininemia Drugs Sales by Type (2016-2021e) & (K MT)
Table 53. Europe Argininemia Drugs Sales by Type (2021-2026) & (K MT)
Table 54. Europe Argininemia Drugs Sales by Application (2016-2021e) & (K MT)
Table 55. Europe Argininemia Drugs Sales by Application (2021-2026) & (K MT)
Table 56. Asia-Pacific Argininemia Drugs Sales by Region (2016-2021e) & (K MT)
Table 57. Asia-Pacific Argininemia Drugs Sales by Region (2021-2026) & (K MT)
Table 58. Asia-Pacific Argininemia Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Argininemia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Argininemia Drugs Sales by Type (2016-2021e) & (K MT)
Table 61. Asia-Pacific Argininemia Drugs Sales by Type (2021-2026) & (K MT)
Table 62. Asia-Pacific Argininemia Drugs Sales by Application (2016-2021e) & (K MT)
Table 63. Asia-Pacific Argininemia Drugs Sales by Application (2021-2026) & (K MT)
Table 64. South America Argininemia Drugs Sales by Country (2016-2021e) & (K MT)
Table 65. South America Argininemia Drugs Sales by Country (2021-2026) & (K MT)
Table 66. South America Argininemia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Argininemia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Argininemia Drugs Sales by Type (2016-2021e) & (K MT)
Table 69. South America Argininemia Drugs Sales by Type (2021-2026) & (K MT)
Table 70. South America Argininemia Drugs Sales by Application (2016-2021e) & (K MT)
Table 71. South America Argininemia Drugs Sales by Application (2021-2026) & (K MT)
Table 72. Middle East & Africa Argininemia Drugs Sales by Country (2016-2021e) & (K MT)
Table 73. Middle East & Africa Argininemia Drugs Sales by Country (2021-2026) & (K MT)
Table 74. Middle East & Africa Argininemia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Argininemia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Argininemia Drugs Sales by Type (2016-2021e) & (K MT)
Table 77. Middle East & Africa Argininemia Drugs Sales by Type (2021-2026) & (K MT)
Table 78. Middle East & Africa Argininemia Drugs Sales by Application (2016-2021e) & (K MT)
Table 79. Middle East & Africa Argininemia Drugs Sales by Application (2021-2026) & (K MT)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Argininemia Drugs Typical Distributors
Table 83. Argininemia Drugs Typical Customers
List of Figures
Figure 1. Argininemia Drugs Picture
Figure 2. Global Argininemia Drugs Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Argininemia Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drugs Stores
Figure 8. Other
Figure 9. Global Argininemia Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Argininemia Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Argininemia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Argininemia Drugs Sales (2016-2026) & (K MT)
Figure 31. Global Argininemia Drugs Production Capacity (2016-2026) & (K MT)
Figure 32. Global Argininemia Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Argininemia Drugs Market Drivers
Figure 34. Argininemia Drugs Market Restraints
Figure 35. Argininemia Drugs Market Trends
Figure 36. Global Argininemia Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Argininemia Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Argininemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Argininemia Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Argininemia Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Argininemia Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Argininemia Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Argininemia Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Argininemia Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Argininemia Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Argininemia Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Argininemia Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Argininemia Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Argininemia Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Argininemia Drugs Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Argininemia Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Argininemia Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Argininemia Drugs Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Argininemia Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Argininemia Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Argininemia Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Argininemia Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Argininemia Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Argininemia Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Argininemia Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Argininemia Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Argininemia Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Argininemia Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Argininemia Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Argininemia Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Argininemia Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Argininemia Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Argininemia Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Argininemia Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Argininemia Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Argininemia Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Argininemia Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Argininemia Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の新規経口抗凝固薬市場 2021：企業別、地域別、種類・用途別 The Novel Oral Anticoagulants Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- メトトレキサート薬口径薬の世界市場2018-2025 Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.In 2018, the global Methotrexate Oral Solution Drugs market size was xx million US$ and is forec…
- トレチノイン薬の世界市場2018-2025 Tretinoin is medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream or ointment. For leukemia, it is taken by mouth for up to three months.In 2018, the global Tretinoin Drugs market size was xx million US$ and is forecast to xx mill…
- メルカプトプリン経口液剤の世界市場2018-2025 Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. In 2018, the global Mercaptopurine Oral Solution Drugs market size was xx million US$ and is forecast to xx million US in 202…
- 硫酸ビンクリスチンリポソーム注射薬の世界市場2018-2025 Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration.In 2018, the global Vincristine Sulfate Liposome Injection Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CA…